Nomura Holdings Inc. boosted its holdings in shares of Danaher Corporation (NYSE:DHR) by 900.4% in the second quarter, according to its most recent filing with the SEC. The firm owned 52,160 shares of the conglomerate’s stock after acquiring an additional 46,946 shares during the period. Nomura Holdings Inc.’s holdings in Danaher Corporation were worth $4,403,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in DHR. Tiedemann Wealth Management LLC boosted its position in shares of Danaher Corporation by 3.1% during the first quarter. Tiedemann Wealth Management LLC now owns 2,920 shares of the conglomerate’s stock worth $250,000 after purchasing an additional 89 shares in the last quarter. Baird Financial Group Inc. lifted its position in Danaher Corporation by 6.1% during the 1st quarter. Baird Financial Group Inc. now owns 175,089 shares of the conglomerate’s stock worth $14,975,000 after buying an additional 10,102 shares in the last quarter. Penserra Capital Management LLC lifted its position in Danaher Corporation by 12.1% during the 1st quarter. Penserra Capital Management LLC now owns 15,454 shares of the conglomerate’s stock worth $1,321,000 after buying an additional 1,670 shares in the last quarter. Bronfman E.L. Rothschild L.P. lifted its position in Danaher Corporation by 30.7% during the 1st quarter. Bronfman E.L. Rothschild L.P. now owns 17,947 shares of the conglomerate’s stock worth $1,535,000 after buying an additional 4,219 shares in the last quarter. Finally, Financial Enhancement Group LLC lifted its position in Danaher Corporation by 3.1% during the 1st quarter. Financial Enhancement Group LLC now owns 57,468 shares of the conglomerate’s stock worth $4,915,000 after buying an additional 1,730 shares in the last quarter. 75.61% of the stock is owned by hedge funds and other institutional investors.
In related news, Director Donald J. Ehrlich sold 10,578 shares of the company’s stock in a transaction dated Tuesday, October 24th. The shares were sold at an average price of $90.82, for a total value of $960,693.96. Following the transaction, the director now owns 104,621 shares in the company, valued at approximately $9,501,679.22. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the company’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $92.64, for a total transaction of $11,671,620.96. Following the completion of the transaction, the chief executive officer now owns 271,737 shares in the company, valued at approximately $25,173,715.68. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 279,628 shares of company stock valued at $25,304,394. Company insiders own 12.20% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Danaher Corporation (DHR) Stake Boosted by Nomura Holdings Inc.” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright law. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2017/11/12/danaher-corporation-dhr-shares-bought-by-nomura-holdings-inc.html.
Danaher Corporation (NYSE:DHR) opened at $92.24 on Friday. Danaher Corporation has a 12 month low of $76.27 and a 12 month high of $93.36. The firm has a market cap of $64,162.60, a price-to-earnings ratio of 23.71, a price-to-earnings-growth ratio of 2.19 and a beta of 1.02. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.05. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The company had revenue of $4.53 billion for the quarter, compared to analyst estimates of $4.47 billion. During the same period last year, the firm earned $0.87 earnings per share. The firm’s revenue was up 9.6% on a year-over-year basis. equities research analysts anticipate that Danaher Corporation will post 3.99 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Friday, September 29th were issued a $0.14 dividend. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.61%. Danaher Corporation’s payout ratio is 16.52%.
Several research firms have recently weighed in on DHR. Jefferies Group LLC restated a “buy” rating and set a $95.00 price objective on shares of Danaher Corporation in a research note on Friday, August 4th. Zacks Investment Research upgraded shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price objective on the stock in a research note on Thursday, October 5th. Cowen and Company restated a “buy” rating and set a $90.00 price objective on shares of Danaher Corporation in a research note on Wednesday, October 4th. Citigroup Inc. set a $96.00 price target on shares of Danaher Corporation and gave the company a “buy” rating in a research note on Friday, July 21st. Finally, BidaskClub upgraded shares of Danaher Corporation from a “sell” rating to a “hold” rating in a research note on Wednesday, July 19th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $93.31.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.